Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
Mou Wen, Yuanlin Ying, Xiang Xiao, Preston R. Arnold, Guangchuan Wang, Xiufeng Chu, Rafik M. Ghobrial, Xian C. Li
Mou Wen, Yuanlin Ying, Xiang Xiao, Preston R. Arnold, Guangchuan Wang, Xiufeng Chu, Rafik M. Ghobrial, Xian C. Li
View: Text | PDF
Research Article Immunology

Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia

  • Text
  • PDF
Abstract

BRD4 is a bromodomain extraterminal domain family member and functions primarily as a chromatin reader regulating genes involved in cell-fate decisions. Here, we bred Brd4fl/fl Ox40-Cre mice in which Brd4 was conditionally deleted in OX40-expressing cells to examine the role of BRD4 in regulating immune responses. We found that the Brd4fl/fl Ox40-Cre mice developed profound alopecia and dermatitis, while other organs and tissues were not affected. Surprisingly, lineage-tracing experiments using the Rosa26fl/fl-Yfp mice identified a subset of hair follicle stem cells (HFSCs) that constitutively express OX40, and deletion of Brd4 specifically in such HFSCs resulted in cell death and a complete loss of skin hair growth. We also found that death of HFSCs triggered massive activation of the intradermal γδ T cells, which induced epidermal hyperplasia and dermatitis by producing the inflammatory cytokine IL-17. Interestingly, deletion of Brd4 in Foxp3+ Tregs, which also constitutively express OX40, compromised their suppressive functions, and this, in turn, contributed to the enhanced activation of γδ T cells, as well as the severity of dermatitis and hair follicle destruction. Thus, our data demonstrate an unexpected role of BRD4 in regulating skin follicle stem cells and skin inflammation.

Authors

Mou Wen, Yuanlin Ying, Xiang Xiao, Preston R. Arnold, Guangchuan Wang, Xiufeng Chu, Rafik M. Ghobrial, Xian C. Li

×

Figure 7

Brd4 deletion in Tregs impairs their suppressive functions contributing to γδ T cell activation and skin inflammation.

Options: View larger image (or click on image) Download as PowerPoint

Brd4 deletion in Tregs impairs their suppressive functions contributing...
(A) In vitro suppression assays based on CFSE dilutions comparing suppressive functions of Foxp3+ Tregs from control Ox40-Cre, Brd4fl/fl Ox40-Cre, and Brd4fl/flCd4-Cre mice. The ratio between Tregs and T effectors are indicated (left). The percentage of proliferating responder T cells at different T effector/Treg ratios is shown in the histogram (right). n = 3. (B) Schematic diagram showing adoptive transfer of WT Tregs (CD45.1+) to Brd4fl/fl Ox40-Cre recipients. (C) Flow cytometric analysis of Foxp3+ Tregs and T effectors gated onto CD4+ cells from peripheral lymph nodes of CD45.1+ Treg recipients compared with nontransferred (N/A) mice (14 weeks old) (left) and frequency of CD44+CD62L– cells in the recipients (right). n = 3. (D) Graph shows average disease score for CD45.1+ Treg recipients compared with N/A mice over time. n = 5–7. (E) Gross appearance of dorsal skin of CD45.1+ Treg recipients compared with N/A mice at 10 weeks and 14 weeks age. (F) Skin sections (H&E staining) of N/A mice and CD45.1+ Treg recipients. Scale bar: 150 μm. (G) Flow cytometry analysis of intracellular expression of cytokines (IL-17A, IL-17F, and IFN-γ) in γδ T cells isolated from skin of CD45.1+ Treg recipients compared with N/A mice at 14 weeks old (left), and frequency of IL-17A+IL-17F+ or IL-17A+IFN-γ+ cells (right). n = 3. Data shown are representative results from 2 experiments (A) and 3 experiments (C and E–G). Graphs shown as mean ± SD. *P < 0.05, **P < 0.01, by 1-way ANOVA (A) or 2-tailed Student’s t test (C, D, and G).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts